Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

PARVOVIRUS B 19 - ANVISA Registration 10339840547

Access comprehensive regulatory information for PARVOVIRUS B 19 in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840547 and manufactured by manufacturer not specified. The registration is held by DIASORIN LTDA with validity until Oct 23, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including DIASORIN ITALIA S.P.A., DIASORIN MOLECULAR LLC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10339840547
2 Related Devices
Registration Details
ANVISA Registration Number: 10339840547
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Família LIAISON® Biotrin Parvovírus B19 IgG Plus
Risk Class III

Registration Details

10339840547

25351454286202395

01896764000170

Company Information

Dates and Status

Oct 23, 2023

23/10/2033

09/18/2025 19:00:01

Família LIAISON® Biotrin Parvovírus B19 IgG Plus
Risk Class III

Registration Details

10339840547

25351454286202395

01896764000170

Company Information

Italy
PT: ITÁLIA

Dates and Status

Oct 23, 2023

23/10/2033

09/18/2025 19:00:01